Authors' objectives: This report aims to summarise the available evidence on the use of the Bard(R) endoscopic suturing system for the treatment of gastroesophageal reflux.

Authors' recommendations: Clearance has been given by the US Food and Drug Administration to market the Bard(R) Endoscopic Suturing System to treat, gastroesophageal reflux disease. During the suturing procedure, a thin, flexible endoscopic tube is inserted down the patient's throat. A device at the end of the endoscope, is used to place sutures in two different locations near the lower esophageal sphincter. The suturing material is then tied together to "tighten" the valve, thus preventing stomach contents from flowing back up into the esophagus. The procedure is performed on an outpatient basis; general anesthesia is generally not required. Patients can typically return to normal activities the next day. The manufacturer is to provider a training and clinical support program for this product. It is estimated that over 70,000 anti-reflux surgeries were performed in the US in 1999.

Authors' methods: Overview

Project Status: Completed

Year Published: 2000

URL for published report: https://www.ihe.ca/advanced-search?type=1020

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Institute of Health Economics

Contact Address: 1200, 10405 Jasper Avenue, Edmonton, Alberta, Canada, T5J 3N4. Tel: +1 780 448 4881; Fax: +1 780 448 0018;

Contact Name: djuzwishin@ihe.ca

Contact Email: djuzwishin@ihe.ca

Copyright: Alberta Heritage Foundation for Medical Research (AHFMR)